The daily business briefing: August 27, 2020

TikTok's CEO resigns as 'political environment' shifts, Moderna says COVID-19 vaccine shows promise among elderly, and more

This photo taken on November 21, 2019, shows the logo of the social media video sharing app Tiktok displayed on a tablet screen in Paris.
(Image credit: LIONEL BONAVENTURE/AFP via Getty Images)

1. TikTok CEO steps down, citing new 'political environment'

TikTok CEO Kevin Mayer announced early Thursday that he had resigned just three months after taking the job, because the "political environment has sharply changed." President Trump says the popular short-video app, owned by China's ByteDance, is a security risk, and he has ordered a ban on the social media company unless its U.S. operations are sold to an American company. ByteDance is suing the Trump administration over the executive order, but also talking to Microsoft about a potential sale. "I have done significant reflection on what the corporate structural changes will require, and what it means for the global role I signed up for," Mayer said. TikTok will be led on an interim basis by U.S. General Manager Vanessa Pappas.

2. Moderna says its COVID-19 vaccine shows promise among elderly

Moderna said Wednesday that its potential COVID-19 vaccine induced promising immune responses in older adults during an early-stage clinical trial. The biotech firm tested its experimental vaccine on 10 adults between 56 and 70, and 10 aged 71 and older. The older patients produced neutralizing antibodies believed necessary to build immunity at similar rates as the younger patients. The news offered hope for protecting older people who have been identified as vulnerable to severe complications from COVID-19. Moderna is among the leading firms racing to develop a coronavirus vaccine. Its candidate, mRNA-1273, is undergoing late-stage human trials to judge its safety and effectiveness.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

Reuters

3. Bezos becomes 1st person with net worth above $200 billion

Amazon chief Jeff Bezos on Wednesday became the first person with a net worth of more than $200 billion in the four decades Forbes has tracked the wealth of the world's richest people. Bezos' wealth surged by $4.9 billion on Wednesday as Amazon's stock gained 2 percent, pushing his net worth to $204.6 billion, $90 billion more than that of the world's second richest person, Microsoft co-founder Bill Gates. And Bezos' fortune took a hit last year, when ex-wife MacKenzie Scott received 25 percent of his Amazon stake in their divorce settlement. Even adjusted for inflation, Bezos' current fortune is the biggest in history. Gates was the first person to cross the $100-billion milestone. In 1999, near the height of the dot-com bubble, Gates' net worth surpassed $100 billion to about $158 billion in today's dollars.

Forbes

4. Novavax CEO says filing for U.S. approval of COVID-19 vaccine expected in December

Novavax expects to file for U.S. approval of its experimental coronavirus vaccine in December, CEO Stanley Erck told Czech newspaper Hospodarske Noviny in an interview released Thursday. Erck said that since part of the vaccine will be produced in the company's Czech plant that country will have access to the product, too. Novavax on Monday announced that it had started lining up volunteers for the second phase of its vaccine candidate's clinical trials. Abbott Laboratories said on Wednesday that it had won U.S. marketing authorization for its COVID-19 portable antigen test, which can provide results within 15 minutes. The test, about the size of a credit card, could be used to screen people at large gatherings. It will sell for $5.

Reuters

5. Stock futures fall ahead of Powell speech

U.S. stock index futures edged down early Thursday as investors awaited an address from Federal Reserve Chair Jerome Powell. Futures for the Dow Jones Industrial Average, the S&P 500, and the Nasdaq were all down by 0.2 percent or more. Powell is speaking at the Fed's annual symposium in Jackson Hole, Wyoming, where he is expected to introduce a new pandemic-era tool to fight economic fallout from the coronavirus pandemic. Powell is expected to acknowledge that inflation is lagging below the central bank's 2 percent target, and signal greater flexibility on inflation, with the Fed shifting to an "average inflation" target because periods of below-average price growth can offset periods of high inflation.

CNBC

Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.